Jane Street
LPCN icon

Jane Street’s Lipocine LPCN Stock Holding History

Jane Street’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$160K Buy
20,027
+9,453
+89% +$82.4K ﹤0.01% 10336
2025
Q4 		$84.9K Buy
+10,574
New +$35.6K ﹤0.01% 10265
2023
Q2 		– Sell
-2,404
Closed -$13K – 9201
2023
Q1 		$13K Buy
2,404
+1,433
+148% +$11.1K ﹤0.01% 8710
2022
Q4 		$6.57K Sell
971
-884
-48% -$6.44K ﹤0.01% 8826
2022
Q3 		$14K Buy
1,855
+274
+17% +$3.06K ﹤0.01% 9274
2022
Q2 		$22K Sell
1,581
-228
-13% -$3.55K ﹤0.01% 9136
2022
Q1 		$42K Buy
1,809
+477
+36% +$9.98K ﹤0.01% 9745
2021
Q4 		$22K Sell
1,332
-873
-40% -$16.2K ﹤0.01% 9773
2021
Q3 		$41K Buy
+2,205
New +$48.7K ﹤0.01% 9611
2021
Q2 		– Sell
-1,709
Closed -$44K – 10142
2021
Q1 		$44K Buy
+1,709
New +$49.3K ﹤0.01% 8861
2017
Q3 		– Sell
-1,440
Closed -$98K – 4813
2017
Q2 		$98K Buy
+1,440
New +$93.9K ﹤0.01% 4167

Other funds holding LPCN

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Jane Street's LPCN Position: Q1 2026 in Review

Jane Street increased its Lipocine (LPCN) stake by 89% in Q1 2026, buying an estimated $82.4K and bringing the position to 20,027 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #10336.

Jane Street first reported a position in LPCN in Q2 2017 and has held it in 11 quarters since. 47 funds tracked by Wall St. Rank hold LPCN as of Q1 2026.

  • Jane Street held 20,027 shares of Lipocine worth $160K as of Q1 2026.
  • Jane Street bought 9,453 Lipocine shares in Q1 2026, an estimated $82.4K.
  • Lipocine made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10336 holding.
  • Jane Street first reported a position in Lipocine in Q2 2017 and has held it in 11 quarters since.
  • 47 funds tracked by Wall St. Rank held Lipocine as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.